Is hydroxychloroquine beneficial for COVID-19 patients?

被引：62
作者：
Li, Xing [1 ]
Wang, Ying [2 ]
Agostinis, Patrizia [3 ]
Rabson, Arnold [4 ]
Melino, Gerry [5 ]
Carafoli, Ernesto [6 ]
Shi, Yufang [2 ,7 ]
Sun, Erwei [1 ,8 ]
机构：
[1] Southern Med Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, 183 Zhongshan Ave West, Guangzhou 510630, Guangdong, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China
[3] Katholieke Univ Leuven, VIB KU Leuven Ctr Canc Biol, Leuven, Belgium
[4] Rutgers State Univ, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA
[5] Univ Roma Tor Vergata, TOR, I-00133 Rome, Italy
[6] Univ Padua, Venetian Inst Mol Med, Rome, Italy
[7] Soochow Univ, State Key Lab Radiat Med & Protect, Affiliated Hosp 1, Inst Translat Med,Med Coll, Suzhou, Peoples R China
[8] Southern Med Univ, Shunde Hosp, Dept Rheumatol & Immunol, Peoples Hosp Shunde 1, Foshan 528000, Guangdong, Peoples R China
来源：
CELL DEATH & DISEASE | 2020年 / 11卷 / 07期
关键词：
ANTIMALARIAL-DRUGS; CHLOROQUINE; INFECTION; INHIBIT; CELLS;
D O I：
10.1038/s41419-020-2721-8
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019. As similar cases rapidly emerged around the world(1-3), the World Health Organization (WHO) declared a public health emergency of international concern on January 30, 2020 and pronounced the rapidly spreading coronavirus outbreak as a pandemic on March 11, 2020(4). The virus has reached almost all countries of the globe. As of June 3, 2020, the accumulated confirmed cases reached 6,479,405 with more than 383,013 deaths worldwide. The urgent and emergency care of COVID-19 patients calls for effective drugs, in addition to the beneficial effects of remdesivir(5), to control the disease and halt the pandemic.
引用
收藏
页数：6
相关论文
共 68 条
  • [11] A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye
    Costedoat-Chalumeau, Nathalie
    Dunogue, Bertrand
    Leroux, Gaelle
    Morel, Nathalie
    Jallouli, Moez
    Le Guern, Veronique
    Piette, Jean-Charles
    Brezin, Antoine P.
    Melles, Ronald B.
    Marmor, Michael F.
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2015, 49 (03) : 317 - 326
  • [12] Hydroxychloroquine: A multifaceted treatment in lupus
    Costedoat-Chalumeau, Nathalie
    Dunogue, Bertrand
    Morel, Nathalie
    Le Guern, Veronique
    Guettrot-Imbert, Gaelle
    [J]. PRESSE MEDICALE, 2014, 43 (06): : E167 - E180
  • [13] Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis
    Dai, Chongshan
    Xiao, Xilong
    Li, Daowen
    Tun, Sun
    Wang, Ying
    Velkov, Tony
    Tang, Shusheng
    [J]. CELL DEATH & DISEASE, 2018, 9
  • [14] New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
    Devaux, Christian A.
    Rolain, Jean-Marc
    Colson, Philippe
    Raoult, Didier
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (05)
  • [15] Chloroquine and hydroxychloroquine in covid-19
    Ferner, Robin E.
    Aronson, Jeffrey K.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [16] Safety management of the treatment with antimalarial drugs in rheumatology. Interdisciplinary recommendations based on a systematic literature search
    Fiehn, C.
    Ness, T.
    Weseloh, C.
    Speckee, C.
    Hadjiski, D.
    Detert, J.
    Krueger, K.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (02): : 186 - 194
  • [17] Funck-Brentano Christian, 2020, Lancet, DOI 10.1016/S0140-6736(20)31174-0
  • [18] Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
    Gao, Jianjun
    Tian, Zhenxue
    Yang, Xu
    [J]. BIOSCIENCE TRENDS, 2020, 14 (01) : 72 - 73
  • [19] Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
    Gautret, Philippe
    Lagier, Jean-Christophe
    Parola, Philippe
    Van Thuan Hoang
    Meddeb, Line
    Mailhe, Morgane
    Doudier, Barbara
    Courjon, Johan
    Giordanengo, Valerie
    Vieira, Vera Esteves
    Dupont, Herve Tissot
    Honore, Stephane
    Colson, Philippe
    Chabriere, Eric
    La Scola, Bernard
    Rolain, Jean-Marc
    Brouqui, Philippe
    Raoult, Didier
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
  • [20] Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
    Geleris, Joshua
    Sun, Yifei
    Platt, Jonathan
    Zucker, Jason
    Baldwin, Matthew
    Hripcsak, George
    Labella, Angelena
    Manson, Daniel K.
    Kubin, Christine
    Barr, R. Graham
    Sobieszczyk, Magdalena E.
    Schluger, Neil W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25) : 2411 - 2418
1234567